Main > ONCOLOGY (**) > Ovarian Cancer MET Pt-Sensitive R** > Treatment > Co: USA. J. DoxoRubicin Liposome>

---

Co: USA. J. DoxoRubicin Liposome>'s subsections
(*) USA Approval Dates: ?
>MET or R>Pt CT
Company
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 2
Patent>USA Expiration: 2020. 04.21.
TradeMark
TradeMark Web-Site

Co: USA. J. DoxoRubicin Liposome>'s products
This section has no products